Please login to the form below

Not currently logged in
Email:
Password:

Lilly taps new communications VP

Eli Lilly has named Jeffrey A Winton as its new vice president of communications

Eli Lilly has named Jeffrey A Winton as its new vice president of communications. This will include responsibility for corporate and product communications, employee communications, issues management, and digital and social communications.

Winton will assume his new role at Lilly on October 11. He will serve as a member of the company's Global Corporate Affairs Leadership Team and will report to Bart Peterson, the former mayor of Indianapolis who became Lilly's senior vice president, corporate affairs and communications, in June of last year.

Winton most recently served as managing partner of West Mill Consulting, a strategic communications and PR company that he founded.  Along with its communications services, the consulting firm also offered executive placement, marketing research, and printing and promotions, with a focus on the healthcare, consumer, beauty, travel and financial services sectors.

While at West Mill, Winton served as interim head, communications and public relations for Bayer Healthcare Pharmaceuticals.

Earlier in his career, he held positions including group vice president, global communications at Schering-Plough and vice president, global public relations at Pharmacia.

22nd September 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics